Characterization of CD4-gp120 activation intermediates during human immunodeficiency virus type 1 syncytium formation

T K Hart1, A Truneh, P J Bugelski

  • 1Department of Toxicology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406, USA.